Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 4 Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Lymphoma 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Squamous Cell 2 Brain Neoplasms 2 Adenocarcinoma 2 Urticaria 1 Tuberous Sclerosis 1 Thrombosis 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Small Cell Lung Carcinoma 1 Severe Combined Immunodeficiency 1 Sarcoma 1 Salivary Gland Neoplasms 1 Renal Insufficiency, Chronic 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Dysautonomias 1 Polycythemia Vera 1 Polycythemia 1 Polycystic Ovary Syndrome 1 Pancreatitis, Chronic 1 Pancreatitis 1 Pancreatic Cyst 1 Ovarian Neoplasms 1

Interventions

Everolimus 5 Temozolomide 4 sargramostim 2 montanide ISA 51 2 lutetium Lu 177 dotatate 2 incomplete Freund's adjuvant 2 Sunitinib 2 Specimen Handling 2 Sorafenib 2 Octreotide 2 Magnetic Resonance Spectroscopy 2 Leucovorin 2 Fluorouracil 2 Cytoreduction Surgical Procedures 2 Colony-Stimulating Factors 2 Bevacizumab 2 surufatinib 1 recombinant interferon alpha 2b-like protein 1 pentetreotide 1 pasireotide 1 nimotuzumab 1 ibrutinib 1 ganitumab 1 gallium Ga 68 dotatate 1 fludarabine phosphate 1 cabozantinib 1 atezolizumab 1 abemaciclib 1 Wound Healing 1 Thalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Adenoma, Islet Cell × Phlebotomy × Clear all

NCT03741517 2022-05-18

Biomarker Study of Pancreatic Neuroendocrine Tumours

Uppsala University

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡